• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 与癌症。

MicroRNAs in cancer.

机构信息

Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210; email:

出版信息

Annu Rev Pathol. 2014;9:287-314. doi: 10.1146/annurev-pathol-012513-104715. Epub 2013 Sep 25.

DOI:10.1146/annurev-pathol-012513-104715
PMID:24079833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4009396/
Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that typically inhibit the translation and stability of messenger RNAs (mRNAs), controlling genes involved in cellular processes such as inflammation, cell-cycle regulation, stress response, differentiation, apoptosis, and migration. Thus, miRNAs have been implicated in the regulation of virtually all signaling circuits within a cell, and their dysregulation has been shown to play an essential role in the development and progression of cancer. Here, after a brief description of miRNA genomics, biogenesis, and function, we discuss the effects of miRNA dysregulation in the cellular pathways that lead to the progressive conversion of normal cells into cancer cells and the potential to develop new molecular miRNA-targeted therapies.

摘要

微小 RNA(miRNA)是一类小的非编码 RNA,通常可以抑制信使 RNA(mRNA)的翻译和稳定性,从而调控细胞过程中的基因,如炎症、细胞周期调控、应激反应、分化、凋亡和迁移。因此,miRNA 参与调控细胞内几乎所有的信号通路,其失调在癌症的发生和发展中起着至关重要的作用。在此,我们在简要描述 miRNA 的基因组学、生物发生和功能之后,讨论了 miRNA 失调对导致正常细胞向癌细胞逐渐转化的细胞通路的影响,以及开发新的分子 miRNA 靶向治疗的潜力。

相似文献

1
MicroRNAs in cancer.微小 RNA 与癌症。
Annu Rev Pathol. 2014;9:287-314. doi: 10.1146/annurev-pathol-012513-104715. Epub 2013 Sep 25.
2
MicroRNAs in human cancer.人类癌症中的 microRNAs。
Adv Exp Med Biol. 2013;774:1-20. doi: 10.1007/978-94-007-5590-1_1.
3
MicroRNAs: molecular features and role in cancer.微小 RNA:分子特征及其在癌症中的作用。
Front Biosci (Landmark Ed). 2012 Jun 1;17(7):2508-40. doi: 10.2741/4068.
4
Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.基于系统生物学的合作 microRNA 作为癌症单药或辅助治疗的研究。
Nucleic Acids Res. 2019 Sep 5;47(15):7753-7766. doi: 10.1093/nar/gkz638.
5
Function of microRNA-143 in different signal pathways in cancer: New insights into cancer therapy.微小RNA-143在癌症不同信号通路中的作用:癌症治疗新见解
Biomed Pharmacother. 2017 Jul;91:121-131. doi: 10.1016/j.biopha.2017.04.060. Epub 2017 Apr 25.
6
MicroRNAs in apoptosis, autophagy and necroptosis.细胞凋亡、自噬和坏死性凋亡中的微小RNA
Oncotarget. 2015 Apr 20;6(11):8474-90. doi: 10.18632/oncotarget.3523.
7
The Roles of miR-25 and its Targeted Genes in Development of Human Cancer.miR-25及其靶向基因在人类癌症发展中的作用
Microrna. 2016;5(2):113-119. doi: 10.2174/2211536605666160905093429.
8
Biological functions of microRNAs: a review.miRNAs 的生物学功能:综述
J Physiol Biochem. 2011 Mar;67(1):129-39. doi: 10.1007/s13105-010-0050-6. Epub 2010 Oct 28.
9
Network analysis of microRNAs and their regulation in human ovarian cancer.人类卵巢癌中微小RNA的网络分析及其调控
BMC Syst Biol. 2011 Nov 3;5:183. doi: 10.1186/1752-0509-5-183.
10
MicroRNA-221: biogenesis, function and signatures in human cancers.MicroRNA-221:生物发生、功能和在人类癌症中的特征。
Eur Rev Med Pharmacol Sci. 2018 May;22(10):3094-3117. doi: 10.26355/eurrev_201805_15069.

引用本文的文献

1
Identifying potential miRNA-disease associations through an accurate matrix completion approach.通过精确的矩阵补全方法识别潜在的微小RNA与疾病的关联。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf444.
2
Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to 2024: research trends, hotspots, and prospects.2010年至2024年宫颈癌与微小RNA研究的文献计量分析:研究趋势、热点与展望
Discov Oncol. 2025 Aug 27;16(1):1639. doi: 10.1007/s12672-025-03106-w.
3
MiRNA-153 attenuates progression of non-small cell lung cancer through targeting positive regulatory/SET domain 2.

本文引用的文献

1
The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.异时性 microRNA let-7 通过调控乳腺癌细胞骨架肌动蛋白途径中的基因抑制细胞迁移。
Mol Cancer Res. 2013 Mar;11(3):240-50. doi: 10.1158/1541-7786.MCR-12-0432. Epub 2013 Jan 21.
2
MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.miR-34b 作为一种肿瘤抑制因子发挥作用,并作为与 Met 反馈回路的节点。
Int J Oncol. 2013 Mar;42(3):957-62. doi: 10.3892/ijo.2013.1767. Epub 2013 Jan 10.
3
Interactive exploration of RNA22 microRNA target predictions.
微小RNA-153通过靶向正调控/SET结构域2来减缓非小细胞肺癌的进展。
Afr Health Sci. 2024 Sep;24(3):194-204. doi: 10.4314/ahs.v24i3.24.
4
Smoking and alcohol specific alterations in miRNA expression in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中miRNA表达的吸烟和酒精特异性改变
Discov Oncol. 2025 Aug 2;16(1):1458. doi: 10.1007/s12672-025-03308-2.
5
Utility of Urinary miRNA Biomarkers for Canine Urothelial Carcinoma Diagnostics.尿微小RNA生物标志物在犬尿路上皮癌诊断中的应用
Vet Sci. 2025 Jun 27;12(7):621. doi: 10.3390/vetsci12070621.
6
Using deep neural networks and LASSO regression to predict miRNA expression changes based on mRNA data.使用深度神经网络和套索回归基于mRNA数据预测miRNA表达变化。
Front Bioinform. 2025 Jul 8;5:1566162. doi: 10.3389/fbinf.2025.1566162. eCollection 2025.
7
MEIS1‑regulated miR‑488‑3p suppresses the malignant progression of laryngeal squamous cell carcinoma by targeting ACVR1C.MEIS1调控的miR-488-3p通过靶向ACVR1C抑制喉鳞状细胞癌的恶性进展。
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5583. Epub 2025 Jul 19.
8
Prognostic Role of Circulating miR-141 in Early Diagnosis of Colorectal Cancer.循环miR-141在结直肠癌早期诊断中的预后作用
Medicina (Kaunas). 2025 May 28;61(6):1007. doi: 10.3390/medicina61061007.
9
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer.miRTARGET:一种用于识别在癌症中具有潜在治疗或预后价值的微小RNA靶点的综合网络工具。
Neoplasia. 2025 Jun 24;67:101202. doi: 10.1016/j.neo.2025.101202.
10
miR-23b is a negative regulator of tumor suppressing PTPRG in colorectal cancer.miR-23b是结直肠癌中肿瘤抑制因子PTPRG的负调控因子。
Transl Oncol. 2025 Jun 24;59:102447. doi: 10.1016/j.tranon.2025.102447.
交互式探索 RNA22 微 RNA 靶标预测。
Bioinformatics. 2012 Dec 15;28(24):3322-3. doi: 10.1093/bioinformatics/bts615. Epub 2012 Oct 16.
4
Epigenetic regulation of miRNAs in cancer.癌症中 miRNA 的表观遗传调控。
Adv Exp Med Biol. 2013;754:137-48. doi: 10.1007/978-1-4419-9967-2_6.
5
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.WEE1 和 CHK1 介导的顺铂敏感性是由 miR-155 和 miR-15 家族介导的。
Cancer Res. 2012 Nov 15;72(22):5945-55. doi: 10.1158/0008-5472.CAN-12-1400. Epub 2012 Aug 31.
6
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.一个整合的转录调控回路,增强乳腺癌干细胞状态。
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14470-5. doi: 10.1073/pnas.1212811109. Epub 2012 Aug 20.
7
Intact p53-dependent responses in miR-34-deficient mice.miR-34 缺陷型小鼠中完整的 p53 依赖性反应。
PLoS Genet. 2012;8(7):e1002797. doi: 10.1371/journal.pgen.1002797. Epub 2012 Jul 26.
8
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.MicroRNA-122 在肝脏稳态和肝癌发生中发挥着关键作用。
J Clin Invest. 2012 Aug;122(8):2884-97. doi: 10.1172/JCI63455. Epub 2012 Jul 23.
9
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.miR-122 在肝脏中的基本代谢、抗炎和抗肿瘤功能。
J Clin Invest. 2012 Aug;122(8):2871-83. doi: 10.1172/JCI63539. Epub 2012 Jul 23.
10
How does Lin28 let-7 control development and disease?Lin28 通过 let-7 如何控制发育和疾病?
Trends Cell Biol. 2012 Sep;22(9):474-82. doi: 10.1016/j.tcb.2012.06.001. Epub 2012 Jul 9.